Andrew G Long's Net Worth
$7.15 Million
Who is Andrew G Long?
Andrew G Long has an estimated net worth of $7.15 Million. This is based on reported shares across multiple companies, which include OWENS & MINOR INC/VA/, and Insys Therapeutics, Inc..
SEC CIK
Andrew G Long's CIK is 0001714880
Past Insider Trading and Trends
2019 was Andrew G Long's most active year for acquiring shares with 7 total transactions. Andrew G Long's most active month to acquire stocks was the month of February. 2021 was Andrew G Long's most active year for disposing of shares, totalling 4 transactions. Andrew G Long's most active month to dispose stocks was the month of April. 2019 saw Andrew G Long paying a total of $0.00 for 539,149 shares, this is the most they've acquired in one year. In 2021 Andrew G Long cashed out on 34,123 shares for a total of $1,354,175.87, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
OWENS & MINOR INC/VA/ (OMI) Snapshot price: $19.71
EVP, CEO P&HS
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -8.36% | -22.79K |
$24.99 | -$569,397.15 | 249.78K |
Mar 15
| |||
Form 4
| +22.87% | 50.73K |
—
|
—
| 272.56K |
Mar 1
| |||
Form 4
| -34.25% | -115.56K |
—
|
—
| 221.83K |
May 19
| |||
Form 4
| -2.39% | -8.27K |
$18.73 | -$154,822.18 | 337.39K |
May 15
| |||
Form 4
| -2.04% | -7.19K |
$18.39 | -$132,150.54 | 345.65K |
May 11
| |||
Form 4
| -8.66% | -33.47K |
$13.06 | -$437,131.26 | 352.84K |
Mar 15
| |||
Form 4
| +101.83% | 194.9K |
—
|
—
| 386.31K |
Mar 1
| |||
Form 4
| -3.74% | -7.44K |
$21.29 | -$158,440.18 | 191.41K |
Nov 11
| |||
Form 4
| -2.10% | -4.27K |
$36.05 | -$153,825.35 | 198.85K |
May 16
| |||
Form 4
| -3.42% | -7.18K |
$37.62 | -$270,299.70 | 203.12K |
May 11
| |||
Form 4
| +14.66% | 26.89K |
—
|
—
| 210.3K |
Mar 3
| |||
Form 4
| +111.16% | 96.55K |
—
|
—
| 183.41K |
Feb 9
| |||
Form 4
| -16.94% | -17.71K |
$42.16 | -$746,736.74 | 86.86K |
Scheduled
|
Nov 11 - Nov 12
| ||
Form 4
| -9.89% | -11.47K |
$38.56 | -$442,360.32 | 104.57K |
Scheduled
|
Aug 9
| ||
Form 4
| -4.08% | -4.94K |
$33.41 | -$165,078.81 | 116.04K |
May 11
| |||
Form 4
| +29.87% | 27.83K |
—
|
—
| 120.98K |
Mar 1
| |||
Form 4
| -5.21% | -5.12K |
$22.17 | -$113,466.06 | 93.16K |
Nov 11
| |||
Form 4
| +96.55% | 48.28K |
—
|
—
| 98.28K |
May 11
| |||
Form 4
|
∞
| 50K |
—
|
—
| 50K |
Nov 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Insys Therapeutics, Inc. No price found
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +25.15% | 12.47K |
—
|
—
| 62.08K |
Apr 17
| |||
Form 4
| +396.00% | 39.6K |
—
|
—
| 49.6K |
Mar 5 - Jan 25
| |||
Form 4
| +396.00% | 39.6K |
—
|
—
| 49.6K |
Mar 5 - Jan 25
| |||
Form 4
|
∞
| 5K |
—
|
—
| 5K |
Aug 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||